Market Overview

Amneal Pharmaceuticals Reports Q2 Earnings Miss, Lowers Guidance


Amneal Pharmaceuticals (NYSE: AMRX) reported second-quarter earnings of 9 cents per share, which missed the analyst consensus estimate of 14 cents by 35.71%. This is a 62.5% decrease over earnings of 24 cents per share from the same period last year.

The company reported quarterly sales of $404.642 million, which missed the analyst consensus estimate of $428.58 million by 5.59%. This is a 2.21% decrease over sales of $413.787 million the same period last year.

Amneal Pharmaceuticals lowered its fiscal year 2019 EPS guidance from 94 cents-$1.04 to 52 cents-62 cents versus a 61 cent estimate.

Amneal Pharmaceuticals closed Friday at $3.25. The stock has a 52-week high of $24.48 and a 52-week low of $3.18.

Related Links:

Arconic Trades Higher On Q2 Earnings Beat, Raised Guidance

Sealed Air Reports Mixed Q2 Earnings, Raises Guidance

Posted-In: Earnings News Guidance


Related Articles (AMRX)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Univar Reports Q2 Earnings Miss

Jacobs Engineering Reports Q3 Earnings Beat